Ceribell (CBLL) Research & Development (2023 - 2026)
Ceribell (CBLL) posted Research & Development of $22.4 million for Q1 2026, down 62.05% on a QoQ basis from $59.0 million in Q4 2025, and up 427.32% year-over-year from $4.2 million in Q1 2025.
Ceribell (CBLL) Research & Development (2023 - 2026) Analysis & Trends
Ceribell's Research & Development history runs 4 years deep, the most recent figure standing at $22.4 million for Q1 2026.
- Quarterly Research & Development rose 427.32% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.8 million (up 74.61% YoY) and the FY2025 annual result came in at $73.1 million, up 48.98% from the prior year.
- Research & Development was $22.4 million for Q1 2026 at Ceribell, down from $59.0 million in the prior quarter.
- Across five years, Research & Development topped out at $59.0 million in Q4 2025 and bottomed at $2.3 million in Q3 2023.
- A 4-year average of $17.0 million and a median of $10.8 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development surged 442.63% — and 2025, when it plunged 60.21%.
- Ceribell's Research & Development stood at $10.8 million in 2023, then soared by 264.36% to $39.4 million in 2024, then soared by 49.73% to $59.0 million in 2025, then plunged by 62.05% to $22.4 million in 2026.
- Business Quant data shows CBLL's Research & Development at $22.4 million in Q1 2026, $59.0 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.39 Mn |
| Dec 31, 2025 | 59.00 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 17.42 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Dec 31, 2024 | 39.41 Mn |
| Sep 30, 2024 | 12.52 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 10.82 Mn |
| Sep 30, 2023 | 2.31 Mn |